Shanghai Luoman Technologies Inc. (605289.SH) has terminated the simplified procedure for issuing shares to specific objects.
Roman Co., Ltd. (605289.SH) issued an announcement stating that the company's board of directors has reviewed and approved a proposal to terminate the current issuance of shares to specific targets via a simplified procedure, as well as to annul the previously determined issuance targets, allocation results, and related subscription arrangements. Since the announcement of the plan for issuing shares to specific targets via a simplified procedure, the company has actively promoted related work in cooperation with relevant intermediary organizations. Considering the changes in the current capital market environment, along with various factors such as the company's actual situation and development strategy, and after thorough communication and careful evaluation with all relevant parties, the company has decided to terminate this matter.
Shanghai Luoman Technologies Inc. (605289.SH) announced that its board of directors has reviewed and approved a proposal to terminate the issuance of stocks to specific targets through a simplified procedure, and to terminate the previously established issuance targets, allocation results, and related subscription arrangements. Since the company's announcement of this stock issuance plan through a simplified procedure, it has actively advanced related work in collaboration with relevant intermediary institutions. Considering the changes in the current capital market environment, along with the company's actual situation, development strategy planning, and various other factors, and after sufficient communication and careful deliberation with all parties involved, the company has decided to terminate this matter.
Related Articles

TOUYUN BIOTECH (01332) completed the issuance of 123 million shares, raising approximately HKD 14.99 million.

KUAISHOU-W (01024) spent HKD 14,991,800 to repurchase 442,000 shares on September 7.

HUNLICAR GROUP (03638): Zhang Lieyun resigns as executive director
TOUYUN BIOTECH (01332) completed the issuance of 123 million shares, raising approximately HKD 14.99 million.

KUAISHOU-W (01024) spent HKD 14,991,800 to repurchase 442,000 shares on September 7.

HUNLICAR GROUP (03638): Zhang Lieyun resigns as executive director

RECOMMEND





